• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[普卢默腺瘤的治疗:超声引导下经皮乙醇注射与自身免疫的相关性]

[Treatment of Plummer's adenoma: correlation between ultrasonography-guided percutaneous injection of ethanol and autoimmunity].

作者信息

Argalia G, Migliorini D, Salvolini L, Macellari L, Giuseppetti G M, Morosini P P, Arnaldi G, Vecchi A, Gusella P

机构信息

Istituto di Semeiologia, Diagnostica e Terapia Strumentale, Università degli Studi di Ancona.

出版信息

Radiol Med. 1993 Apr;85(4):462-6.

PMID:8516475
Abstract

The authors investigated the value of percutaneous ethanol injection in the treatment of Plummer's adenoma. Ten patients were studied: they exhibited a single, hot and toxic nodule in the thyroid. Thyroid autoimmunization (TSAb; TMAb; TGAb) and function (T3; T4; TSH; FT3; FT4) were studied in all patients, before treatment and at 1 month and 3 months. Scintigraphy with 99Tc was performed at the same time intervals. In the euthyroid stage, alcoholization was preceded by US and cytology. Three-four ml of ethanol 95 degrees were injected once or twice a week, from a minimum of 3 to a maximum of 8 injections. Treatment was successful in 2 cases; partial success was obtained in 4 cases, and in 4 cases treatment failed. In all successful cases antibodies were negative and the nodules had hypoechoic echostructure, with a peripheral hypoechoic halo and no areas of internal colliquation. Thus, US-guided percutaneous alcoholization seems to be capable of correct indications in hypoechoic nodules not exhibiting areas of colliquative necrosis and with negative antibodies. However, the problem of the dose of alcohol to inject to treat the nodule thoroughly is still to be debated.

摘要

作者研究了经皮乙醇注射治疗普卢默腺瘤的价值。对10例患者进行了研究:他们的甲状腺均有单个、热且有毒性的结节。在所有患者治疗前、治疗后1个月和3个月时,研究了甲状腺自身免疫(TSAb;TMAb;TGAb)和功能(T3;T4;TSH;FT3;FT4)。同时在相同时间间隔进行99Tc闪烁扫描。在甲状腺功能正常阶段,乙醇注射前先进行超声检查和细胞学检查。每周注射1次或2次95度乙醇3 - 4毫升,最少注射3次,最多注射8次。2例治疗成功;4例部分成功,4例治疗失败。在所有成功的病例中,抗体均为阴性,结节具有低回声结构,周边有低回声晕,且无内部液化区域。因此,超声引导下经皮乙醇注射似乎能够对无液化坏死区域且抗体阴性的低回声结节做出正确诊断。然而,彻底治疗结节所需乙醇剂量的问题仍有待探讨。

相似文献

1
[Treatment of Plummer's adenoma: correlation between ultrasonography-guided percutaneous injection of ethanol and autoimmunity].[普卢默腺瘤的治疗:超声引导下经皮乙醇注射与自身免疫的相关性]
Radiol Med. 1993 Apr;85(4):462-6.
2
[Ultrasound-guided percutaneous injection of ethanol in Plummer's adenoma. Our experience with 8 patients].[超声引导下经皮乙醇注射治疗普卢默腺瘤。我们对8例患者的经验]
Radiol Med. 1991 Jul-Aug;82(1-2):70-2.
3
[Echo-guided percutaneous alcohol injections of cold non-neoplastic thyroid nodules. Preliminary experience].
Radiol Med. 1993 Jun;85(6):827-30.
4
[Treatment of hot thyroid nodule with percutaneous ethanol injection: indications, complications, and prognostic factors].经皮乙醇注射治疗甲状腺热结节:适应证、并发症及预后因素
Radiol Med. 1996 Jun;91(6):774-80.
5
[Efficacy of treatment of benign thyroid nodules by percutaneous ethanol injection].
Wiad Lek. 2004;57(9-10):403-7.
6
[The treatment of solitary thyroid nodules in non-toxic goiter with 96% ethanol injections].[用96%乙醇注射治疗非毒性甲状腺肿中的孤立性甲状腺结节]
Wiad Lek. 1999;52(9-10):432-40.
7
Percutaneous injection of ethanol to treat autonomous thyroid nodules.经皮注射乙醇治疗自主性甲状腺结节。
AJR Am J Roentgenol. 1993 Oct;161(4):871-6. doi: 10.2214/ajr.161.4.8372778.
8
Percutaneous ethanol injection of autonomously functioning thyroid nodule.经皮乙醇注射治疗自主功能性甲状腺结节
Rays. 1999 Apr-Jun;24(2):348-57.
9
[Treatment of solitary toxic thyroid nodules with the use of percutaneous ethanol injections].[经皮乙醇注射治疗孤立性毒性甲状腺结节]
Wiad Lek. 2000;53(1-2):22-9.
10
Percutaneous ethanol injection of autonomous thyroid nodules with a volume larger than 40 ml: three years of follow-up.经皮乙醇注射治疗体积大于40毫升的自主性甲状腺结节:三年随访
Clin Radiol. 2001 Nov;56(11):895-901. doi: 10.1053/crad.2001.0787.